Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Total Non-Current Liabilities (2016 - 2017)

Historic Total Non-Current Liabilities for Tenax Therapeutics (TENX) over the last 5 years, with Q3 2017 value amounting to $802474.0.

  • Tenax Therapeutics' Total Non-Current Liabilities fell 9368.57% to $802474.0 in Q3 2017 from the same period last year, while for Sep 2017 it was $802474.0, marking a year-over-year decrease of 9368.57%. This contributed to the annual value of $6.0 million for FY2016, which is N/A changed from last year.
  • Per Tenax Therapeutics' latest filing, its Total Non-Current Liabilities stood at $802474.0 for Q3 2017, which was down 9368.57% from $2.1 million recorded in Q2 2017.
  • Over the past 5 years, Tenax Therapeutics' Total Non-Current Liabilities peaked at $12.9 million during Q2 2016, and registered a low of $802474.0 during Q3 2017.
  • Its 4-year average for Total Non-Current Liabilities is $6.8 million, with a median of $5.0 million in 2017.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first plummeted by 5038.66% in 2016, then crashed by 9368.57% in 2017.
  • Tenax Therapeutics' Total Non-Current Liabilities (Quarter) stood at $4.9 million in 2013, then soared by 145.5% to $12.0 million in 2015, then tumbled by 50.39% to $6.0 million in 2016, then plummeted by 86.57% to $802474.0 in 2017.
  • Its Total Non-Current Liabilities stands at $802474.0 for Q3 2017, versus $2.1 million for Q2 2017 and $5.0 million for Q1 2017.